Second Genome Secures $6,500,000 Series A Funding Round

  • Feed Type
  • Date
    6/5/2013
  • Company Name
    Second Genome
  • Mailing Address
    1150 Bayhill Drive San Bruno, CA 94066
  • Company Description
    Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders.
  • Website
    http://www.secondgenome.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The new funding will be used to accelerate programs in metabolic disease, inflammation, and infection.
  • M&A Terms
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Wavepoint Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.